This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Evaluating traditional loans versus credit builder options helps you determine the best path for credit growth based on your situation.
25,423 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
SoundHound AI has delivered notable revenue gains, even as its stock retreated. This article breaks down what's drivi...
Victoria’s Secret defies doubters by ditching perpetual sales and a woke marketing tone, posting stronger-than-expect...
Could Micron Technology stock reach 2000 within a year? This article breaks down the catalysts, the math, and the ris...
Explore ibotta (ibta) 2025 earnings projections, including revenue drivers, user growth, and profitability timelines....
As Rivian gears up for the upcoming earnings release, two major catalysts could shape the stock's trajectory. This gu...
MSGM's Q1 2026 commentary offers a clearer view of the year ahead for investors. This article decodes the msgm 2026 e...
Medtronic stock popped today after the company topped earnings expectations and revenue forecasts. This article expla...
A new Gallup survey ties regular AI use to lower layoff risk in the U.S. job market. The findings challenge the idea...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
A sharp move like integer stock down insider signals attention, not alarm. Learn how to read insider trades, separate...
Evolv Technologies stock plummeted after mixed results that still beat on revenue and nudged full-year guidance highe...